Stopping HPVs dead in their tracts.
Vaccines are currently available to prevent infection of the genital tract and subsequent disease for some human papillomavirus (HPV) types, and attempts to develop broadly cross-reactive HPV vaccines are progressing. A recently developed murine model of cervicovaginal HPV infection examines the mechanisms by which antibodies prevent infection in vivo.